Medical Devices

A new obesity drug shows 19.3% weight loss with remarkably few side effects, while also improving blood pressure, cholesterol, and even bone density.

Now the #2 aligner company globally, Angel Aligner leverages 23+ years of R&D and strategic expansion to challenge industry leaders. Here's how.

From a one-room office to a regional logistics leader, Excel Courier marks four decades of driving critical industries like healthcare and tech.

With a key FDA decision looming, Cristcot hires Rayna Herman to lead the commercial strategy for its first-in-class ulcerative colitis therapy, ngHCA.

RVL Pharmaceuticals claims double-digit growth for its eye drop Upneeq, but as a private firm, its disruptive direct-to-consumer model operates outside public view.

With a promising cancer pipeline, Crescent Biopharma heads to key May conferences to prove its strategy against fierce competition in the bispecific and ADC markets.

As EyePoint's losses widen to fund its lead drug, DURAVYU, the company is on the cusp of pivotal trial results that could redefine retinal disease treatment.

A Marine veteran and stand-up comedian is running for Congress in Florida. Can Tim Wilkins' outsider campaign and conservative platform win over a key district?

Orthofix showcases its new FITBONE internal lengthening implant and AI-enhanced software, offering less invasive, more precise options for young patients.

Amble Health's new program offers 50% off weight loss drugs, but it requires patients to pay cash and potentially use non-FDA-approved medications.

A new 'Buy' rating from a major bank subsidiary shines a light on SMAIO's data-driven approach to complex spine surgery. Here's why investors are noticing.

Medical tech giant Convatec unveils a new arsenal of advanced wound care solutions, using nitric oxide and placental tech to combat hard-to-heal injuries.

As FDA rules on peptides shift, a new AI platform aims to give doctors clarity, separating solid science from speculation in the booming longevity market.

NImmune Biopharma's oral drug NIM-1324 shows promising safety and efficacy, targeting a novel pathway to treat IBD and a host of other diseases.

A new all-in-one system from Sweden's Multi4 Medical just won EU approval, allowing urologists to treat bladder cancer in minutes without surgery.

A new blood test could tell you if GLP-1 drugs will work for you before you start, a major leap for precision medicine in the booming obesity market.

With a star-studded new advisory board, Pilatus Biosciences accelerates its attack on cancer's metabolic defenses with its lead drug, PLT012.

Ottobock and Angel City Sports expand their partnership, using advanced tech and community events to build momentum for the LA28 Paralympic Games.

A new FDA-cleared system offers hope against postpartum hemorrhage, the leading cause of maternal death, earning its maker a prestigious Edison Award.

A new FDA-cleared shoulder implant from FX Shoulder Solutions offers unprecedented flexibility, allowing surgeons to adapt their approach mid-surgery.